Acceleron Pharma Inc NASDAQ:XLRN Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Location: 128 Sidney St, Massachusetts, 02139-4239, US | Website: www.acceleronpharma.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing